NO165543C - Analogifremgangsmaate for fremst av terapeutisk aktiv (4r,5s,6s,8r,2's,-4's)-3- 4-(dimethylamino-carbonyl)-pyrrolidinhylthio -4-methyl-6-(1-hydroxyethyl)-1-azabicyclo- 3,2,0 hept-2-en-7-on-2-carboxylsyre i krystallinsk form. - Google Patents
Analogifremgangsmaate for fremst av terapeutisk aktiv (4r,5s,6s,8r,2's,-4's)-3- 4-(dimethylamino-carbonyl)-pyrrolidinhylthio -4-methyl-6-(1-hydroxyethyl)-1-azabicyclo- 3,2,0 hept-2-en-7-on-2-carboxylsyre i krystallinsk form.Info
- Publication number
- NO165543C NO165543C NO873205A NO873205A NO165543C NO 165543 C NO165543 C NO 165543C NO 873205 A NO873205 A NO 873205A NO 873205 A NO873205 A NO 873205A NO 165543 C NO165543 C NO 165543C
- Authority
- NO
- Norway
- Prior art keywords
- pyrrolidinhylthio
- hept
- dimethylamino
- promotion
- hydroxyethyl
- Prior art date
Links
- HZAVSJRAODFHGF-UHFFFAOYSA-N 2-methyl-7-oxohept-2-enoic acid Chemical compound OC(=O)C(C)=CCCCC=O HZAVSJRAODFHGF-UHFFFAOYSA-N 0.000 title 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical class C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 title 1
- -1 DIMETHYLAMINO-CARBONYL Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17932186 | 1986-07-30 | ||
| JP15776987 | 1987-06-26 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO873205D0 NO873205D0 (no) | 1987-07-30 |
| NO873205L NO873205L (no) | 1988-02-01 |
| NO165543B NO165543B (no) | 1990-11-19 |
| NO165543C true NO165543C (no) | 1991-02-27 |
Family
ID=26485103
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO873205A NO165543C (no) | 1986-07-30 | 1987-07-30 | Analogifremgangsmaate for fremst av terapeutisk aktiv (4r,5s,6s,8r,2's,-4's)-3- 4-(dimethylamino-carbonyl)-pyrrolidinhylthio -4-methyl-6-(1-hydroxyethyl)-1-azabicyclo- 3,2,0 hept-2-en-7-on-2-carboxylsyre i krystallinsk form. |
| NO1997013C NO1997013I1 (no) | 1986-07-30 | 1997-10-17 | Meropenem |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO1997013C NO1997013I1 (no) | 1986-07-30 | 1997-10-17 | Meropenem |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4888344A (fr) |
| EP (1) | EP0256377B1 (fr) |
| JP (1) | JP2665767B2 (fr) |
| AR (1) | AR243189A1 (fr) |
| AU (1) | AU596857B2 (fr) |
| CA (1) | CA1322371C (fr) |
| DE (1) | DE3781980T2 (fr) |
| DK (1) | DK172666B1 (fr) |
| ES (1) | ES2052524T3 (fr) |
| FI (1) | FI88037C (fr) |
| GR (1) | GR3006254T3 (fr) |
| HK (1) | HK169595A (fr) |
| HU (1) | HU199473B (fr) |
| IE (1) | IE60588B1 (fr) |
| IL (1) | IL83372A (fr) |
| LU (1) | LU88635I2 (fr) |
| MX (1) | MX173359B (fr) |
| NO (2) | NO165543C (fr) |
| NZ (1) | NZ221224A (fr) |
| PH (1) | PH24710A (fr) |
Families Citing this family (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1283906C (fr) * | 1983-05-09 | 1991-05-07 | Makoto Sunagawa | COMPOSE DE .beta.-LACTAM ET PROCEDE DE PRODUCTION |
| KR880006244A (ko) * | 1986-11-24 | 1988-07-22 | 후지사와 도모 기찌 로 | 3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법 |
| EP0406863B1 (fr) * | 1989-07-06 | 1995-05-24 | Banyu Pharmaceutical Co., Ltd. | Dérivés cycliques de l'amidinylthiocarbapénème |
| EP0435320B1 (fr) * | 1989-12-29 | 1994-10-05 | Banyu Pharmaceutical Co., Ltd. | Dérivés de 2-(2-cyclopropylpyrrolidin-4-ylthio)carbapénème |
| TW264475B (fr) * | 1991-09-20 | 1995-12-01 | Takeda Pharm Industry Co Ltd | |
| JP2696807B2 (ja) * | 1992-08-06 | 1998-01-14 | 田辺製薬株式会社 | カルバペネム誘導体の製法 |
| GB9503717D0 (en) * | 1995-02-24 | 1995-04-12 | Smithkline Beecham Plc | Novel compounds |
| FR2735474B1 (fr) * | 1995-06-13 | 1997-08-08 | Roussel Uclaf | Chlorhydrate de zilpaterol sous une forme cristallisee particuliere, son procede de preparation et les produits intermediaires mis en oeuvre |
| CZ272099A3 (cs) * | 1997-02-07 | 1999-11-17 | Kyoto Pharmaceutical Industries, Ltd. | Karbapenémové sloučeniny, jejich použití a jejich meziprodukty |
| NZ508493A (en) | 1998-05-01 | 2002-06-28 | Kyoto Pharma Ind | Carbapenem derivatives, utilization thereof and intermediate compounds of the same |
| DE60009695T2 (de) * | 1999-06-03 | 2004-09-23 | Eisai Co., Ltd. | Kristalline cabapenemderivate und pharmazeutische zubereitungen zur injektion |
| US7041660B2 (en) | 1999-07-06 | 2006-05-09 | Sankyo Company, Limited | Crystalline 1-methylcarbapenem derivatives |
| TWI250160B (en) * | 1999-07-06 | 2006-03-01 | Sankyo Co | Crystalline 1-methylcarbapenem compound |
| EP1762236B1 (fr) * | 2000-05-12 | 2015-07-15 | Septodont Holding SAS | Formulations d'antagonistes des récepteurs adrénergiques alpha et leurs utilisations |
| JP5079190B2 (ja) * | 2001-04-27 | 2012-11-21 | 大日本住友製薬株式会社 | アゼチジノン誘導体およびその製造方法 |
| BR0209970A (pt) * | 2001-05-21 | 2004-04-06 | Kyoto Pharma Ind | Composto de carbapenem |
| KR100451672B1 (ko) * | 2001-06-05 | 2004-10-08 | 한미약품 주식회사 | 결정성 세프디니르 산부가염, 이의 제조방법 및 이를이용한 세프디니르의 제조방법 |
| WO2003016312A1 (fr) * | 2001-08-13 | 2003-02-27 | Eisai Co., Ltd. | Procede de preparation d'antibiotiques a base de carbapenem |
| IL160413A0 (en) * | 2001-09-26 | 2004-07-25 | Merck & Co Inc | Process for making carbapenem compounds |
| USRE40794E1 (en) | 2001-09-26 | 2009-06-23 | Merck & Co., Inc. | Crystalline forms of carbapenem antibiotics and methods of preparation |
| ITMI20012364A1 (it) * | 2001-11-09 | 2003-05-09 | Antibioticos Spa | Processo di sintesi della cefixima via alchil-o arilsolfonati |
| IL163666A0 (en) | 2002-02-22 | 2005-12-18 | New River Pharmaceuticals Inc | Active agent delivery systems and methods for protecting and administering active agents |
| US7229630B2 (en) * | 2002-06-20 | 2007-06-12 | Novalar Pharmaceuticals, Inc. | Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof |
| US20030236306A1 (en) * | 2002-06-20 | 2003-12-25 | Chen Andrew X. | Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof |
| JPWO2004024185A1 (ja) | 2002-09-11 | 2006-01-26 | 道男 石橋 | 医薬または化粧料 |
| CN1960992B (zh) * | 2004-06-02 | 2011-10-19 | 桑多斯股份公司 | 晶体形式的美罗培南中间体 |
| WO2006035300A2 (fr) * | 2004-09-30 | 2006-04-06 | Ranbaxy Laboratories Limited | Procede de preparation de meropenem |
| JP4547245B2 (ja) * | 2004-12-16 | 2010-09-22 | 株式会社パーマケム・アジア | ペリンドプリルエルブミンのｉ型結晶、及びその製造方法 |
| US7872050B2 (en) * | 2005-03-14 | 2011-01-18 | Yaupon Therapeutics Inc. | Stabilized compositions of volatile alkylating agents and methods of using thereof |
| US20110039943A1 (en) * | 2005-03-14 | 2011-02-17 | Robert Alonso | Methods for treating skin disorders with topical nitrogen mustard compositions |
| US8501818B2 (en) * | 2005-03-14 | 2013-08-06 | Ceptaris Therapeutics, Inc. | Stabilized compositions of alkylating agents and methods of using same |
| US20070197781A1 (en) * | 2005-07-29 | 2007-08-23 | Neera Tewari | Processes for the preparation of carbapenems |
| SI1926732T1 (sl) | 2005-09-05 | 2014-02-28 | Ranbaxy Laboratories Limited | Postopek za pripravo karbapenskih spojin |
| EP1934221A4 (fr) | 2005-09-15 | 2011-10-26 | Orchid Chemicals & Pharm Ltd | Procede ameliore de preparation d'un antibiotique beta-lactame |
| CN100497338C (zh) * | 2006-01-05 | 2009-06-10 | 上海医药工业研究院 | 4－甲基－7－氧－1－氮杂双环[3.2.0]庚－2－烯－2－羧酸类衍生物的制备方法 |
| KR100781821B1 (ko) * | 2006-02-16 | 2007-12-03 | 문순구 | 카르바페넴계 화합물의 제조방법 |
| EP2006290A4 (fr) * | 2006-03-28 | 2011-01-05 | Kaneka Corp | Procédé amélioré de production d'un composé de carbapenem |
| TW200815442A (en) * | 2006-04-28 | 2008-04-01 | Kaneka Corp | Improved method for the crystallization of intermediates of carbapenem antibiotics |
| JPWO2009075309A1 (ja) * | 2007-12-12 | 2011-04-28 | 大日本住友製薬株式会社 | 製剤組成物 |
| US20090216010A1 (en) * | 2008-02-22 | 2009-08-27 | Wei-Hong Tseng | Crystalline carbapenem compound and produced method thereof |
| EP2098525A1 (fr) | 2008-02-26 | 2009-09-09 | Savior Lifetec Corporation | Composé de carbapenem cristallin et son procédé de production |
| LT2273876T (lt) * | 2008-03-27 | 2019-05-27 | Helsinn Healthcare Sa | Stabilizuotos alkilinimo medžiagų kompozicijos ir jų panaudojimo būdai |
| US8097719B2 (en) * | 2008-07-15 | 2012-01-17 | Genesen Labs | Meropenem intermediate in novel crystalline form and a method of manufacture of meropenem |
| KR20110049823A (ko) * | 2008-07-30 | 2011-05-12 | 랜박시 래보러터리스 리미티드 | 카르바페넴 화합물의 제조 방법 |
| US9233963B2 (en) | 2009-03-13 | 2016-01-12 | Daewoong Pharmaceutical Co., Ltd. | Method for preparing meropenem using zinc powder |
| WO2011048583A1 (fr) | 2009-10-23 | 2011-04-28 | Ranbaxy Laboratories Limited | Procédé pour la préparation de composés de carbapénème |
| WO2011141847A1 (fr) * | 2010-05-10 | 2011-11-17 | Orchid Chemicals And Pharmaceuticals Limited | Procédé amélioré pour la préparation de méropénem |
| WO2012052978A1 (fr) | 2010-10-22 | 2012-04-26 | Ranbaxy Laboratories Limited | Procédé de préparation de méropénème trihydraté pur |
| CN101962383A (zh) * | 2010-11-12 | 2011-02-02 | 上海巴迪生物医药科技有限公司 | 一种美罗培南的合成方法 |
| WO2012081033A2 (fr) * | 2010-12-06 | 2012-06-21 | Sequent Scientific Limited | Procédé de préparation d'imipénem |
| CN102532140B (zh) * | 2010-12-21 | 2015-03-11 | 北大方正集团有限公司 | 一种美罗培南三水合物的制备方法 |
| CN102250096B (zh) * | 2011-09-05 | 2016-04-06 | 江西华邦药业有限公司 | 一种美罗培南的制备方法 |
| CN103570719B (zh) * | 2012-07-31 | 2016-03-02 | 深圳市海滨制药有限公司 | 一种美罗培南原料药、其制备方法及包含其的药物组合物 |
| CN103570718B (zh) * | 2012-07-31 | 2016-06-29 | 深圳市海滨制药有限公司 | 一种美罗培南原料药、其制备方法及包含其的药物组合物 |
| CN103570720B (zh) * | 2012-07-31 | 2016-02-10 | 新乡海滨药业有限公司 | 一种美罗培南原料药、其制备方法及包含其的药物组合物 |
| KR101331762B1 (ko) | 2012-12-28 | 2013-11-20 | 주식회사 대웅제약 | 메로페넴의 삼수화물의 제조방법 |
| CN103044429B (zh) * | 2013-01-28 | 2015-04-01 | 苏州二叶制药有限公司 | 一种美罗培南的制备方法 |
| EP2950800B1 (fr) | 2013-02-01 | 2020-09-09 | Ocuphire Pharma, Inc. | Procédés et compositions pour l'administration ophtalmique quotidienne de phentolamine pour améliorer les performances visuelles |
| ES2762153T3 (es) | 2013-02-01 | 2020-05-22 | Ocuphire Pharma Inc | Soluciones oftálmicas acuosas de fentolamina y usos médicos de las mismas |
| KR102144777B1 (ko) | 2013-06-19 | 2020-08-18 | 제이더블유중외제약 주식회사 | 결정형 메로페넴 삼수화물의 제조방법 |
| US10011603B2 (en) | 2014-03-27 | 2018-07-03 | Johnson Matthey Public Limited Company | Process for preparing a carbapenem antibiotic |
| WO2020081562A1 (fr) | 2018-10-15 | 2020-04-23 | Ocuphire Pharma, Inc. | Méthodes et compositions permettant le traitement du glaucome et d'affections apparentées |
| MX2021004708A (es) | 2018-10-26 | 2021-11-03 | Ocuphire Pharma Inc | Metodos y composiciones para tratamiento de presbicia, midriasis y otros trastornos oculares. |
| CN115368310B (zh) | 2021-05-18 | 2025-06-27 | 奥库菲尔医药公司 | 合成甲磺酸酚妥拉明的方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK153486C (da) * | 1978-07-03 | 1988-11-28 | Merck & Co Inc | Analogifremgangsmaade til fremstilling af krystallinsk n-formimidoyl-thienamycin-monohydrat |
| EP0113101A1 (fr) * | 1982-12-30 | 1984-07-11 | Merck & Co. Inc. | Esters d'acides 6-(1-hydroxyéthyl)-2-SR8-1-méthyl-1-carbadéthiapén-2-ème-3-carboxyliques |
| JPS60104088A (ja) * | 1983-11-11 | 1985-06-08 | Sumitomo Chem Co Ltd | 新規なβ−ラクタム化合物およびその製造法 |
| CA1283906C (fr) * | 1983-05-09 | 1991-05-07 | Makoto Sunagawa | COMPOSE DE .beta.-LACTAM ET PROCEDE DE PRODUCTION |
| US4748238A (en) * | 1984-03-14 | 1988-05-31 | Merck & Co., Inc. | Crystalline 1R,5S,6S,8R-1-methyl-2-(N,N-dimethylcarbamimidoylmethylthio)-6-(1-hydroxyethyl)-1-carbapen-2-em-3-carboxylic acid |
| US4713451A (en) * | 1984-04-09 | 1987-12-15 | Merck & Co., Inc. | Crystalline dimethyliminothienamycin |
| US4761408A (en) * | 1984-11-02 | 1988-08-02 | Ciba-Geigy Corporation | Crystalline aminomethyl compound |
| NZ214691A (en) * | 1984-12-27 | 1988-08-30 | Sumitomo Pharma | The preparation of carbapenem derivatives and beta-lactam intermediates |
| US4788282A (en) * | 1985-06-07 | 1988-11-29 | Bristol-Myers Company | Deprotection of allylic esters and ethers |
-
1987
- 1987-07-20 IE IE195987A patent/IE60588B1/en not_active IP Right Cessation
- 1987-07-28 NZ NZ221224A patent/NZ221224A/xx unknown
- 1987-07-28 AU AU76196/87A patent/AU596857B2/en not_active Expired
- 1987-07-29 IL IL83372A patent/IL83372A/xx not_active IP Right Cessation
- 1987-07-29 DE DE8787110992T patent/DE3781980T2/de not_active Expired - Lifetime
- 1987-07-29 EP EP87110992A patent/EP0256377B1/fr not_active Expired - Lifetime
- 1987-07-29 PH PH35599A patent/PH24710A/en unknown
- 1987-07-29 CA CA000543276A patent/CA1322371C/fr not_active Expired - Lifetime
- 1987-07-29 LU LU88635C patent/LU88635I2/fr unknown
- 1987-07-29 ES ES87110992T patent/ES2052524T3/es not_active Expired - Lifetime
- 1987-07-29 FI FI873299A patent/FI88037C/fi not_active IP Right Cessation
- 1987-07-30 US US07/079,470 patent/US4888344A/en not_active Expired - Lifetime
- 1987-07-30 MX MX753487A patent/MX173359B/es unknown
- 1987-07-30 DK DK198703990A patent/DK172666B1/da not_active IP Right Cessation
- 1987-07-30 HU HU873521A patent/HU199473B/hu unknown
- 1987-07-30 AR AR87308307A patent/AR243189A1/es active
- 1987-07-30 NO NO873205A patent/NO165543C/no not_active IP Right Cessation
-
1988
- 1988-05-16 JP JP63117078A patent/JP2665767B2/ja not_active Expired - Lifetime
-
1992
- 1992-11-16 GR GR920402593T patent/GR3006254T3/el unknown
-
1995
- 1995-11-02 HK HK169595A patent/HK169595A/en not_active IP Right Cessation
-
1997
- 1997-10-17 NO NO1997013C patent/NO1997013I1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK399087D0 (da) | 1987-07-30 |
| NO873205L (no) | 1988-02-01 |
| GR3006254T3 (fr) | 1993-06-21 |
| IE871959L (en) | 1988-01-30 |
| FI873299A0 (fi) | 1987-07-29 |
| IE60588B1 (en) | 1994-07-27 |
| DE3781980T2 (de) | 1993-02-18 |
| AU596857B2 (en) | 1990-05-17 |
| NO165543B (no) | 1990-11-19 |
| PH24710A (en) | 1990-10-01 |
| DK399087A (da) | 1988-01-31 |
| LU88635I2 (fr) | 1995-12-01 |
| HU199473B (en) | 1990-02-28 |
| US4888344A (en) | 1989-12-19 |
| DE3781980D1 (de) | 1992-11-05 |
| HK169595A (en) | 1995-11-10 |
| ES2052524T3 (es) | 1994-07-16 |
| AR243189A1 (es) | 1993-07-30 |
| NO1997013I1 (no) | 1997-10-17 |
| DK172666B1 (da) | 1999-05-10 |
| FI88037B (fi) | 1992-12-15 |
| JPS6434986A (en) | 1989-02-06 |
| HUT44553A (en) | 1988-03-28 |
| FI873299L (fi) | 1988-01-31 |
| NZ221224A (en) | 1989-10-27 |
| MX7534A (es) | 1993-10-01 |
| JP2665767B2 (ja) | 1997-10-22 |
| MX173359B (es) | 1994-02-23 |
| EP0256377B1 (fr) | 1992-09-30 |
| CA1322371C (fr) | 1993-09-21 |
| IL83372A (en) | 1992-05-25 |
| FI88037C (fi) | 1993-03-25 |
| AU7619687A (en) | 1988-03-03 |
| EP0256377A1 (fr) | 1988-02-24 |
| IL83372A0 (en) | 1987-12-31 |
| NO873205D0 (no) | 1987-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO170480C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoksyeddiksyre-derivater | |
| FI88037B (fi) | Foerfarande foer framstaellning av farmaceutiskt vaerdefullt kristallint (4r,5s,6s,8r,2's,4's)-3-/4-(2-dimetylaminokarbonyl)-pyrrolidinyltio/-4-metyl-6-(1-hydroxietyl)-1-azabicyklo-/3,2,0/-hept-2-en-7-on-2-karboxylsyratrihydrat | |
| NO168770C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
| NO163406C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater. | |
| NO168303C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocyklyloksoftalazinyl-eddiksyre-derivater | |
| NO862477D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater. | |
| NO172343C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive askorbinsyrederivater | |
| NO170629C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater | |
| NO862956D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-derivater. | |
| NO167916C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiolaktam-n-eddiksyrederivater | |
| NO170976C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylbuten-syrederivater | |
| NO162155C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylkarbonoksylsyrederivater. | |
| NO168299C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater | |
| NO164982C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
| NO170582C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aryl-piperazinyl-alkylenfenyl-heterocykliske forbindelser | |
| NO169069C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater | |
| NO165069C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere. | |
| NO891114L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater. | |
| NO171211C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner | |
| NO164895C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater. | |
| NO171499C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6-dihydro-4h-cyklo-penta(b)tiofen-6-karboksylsyre-derivater | |
| NO159590C (no) | Analogifremgangsm te for fremstilling av terapeutisk aktive fenyleddiksyre-derivater. | |
| NO167801C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater. | |
| NO166322C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroapovincaminsyrederivater. | |
| NO172583C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktiv penicillansyre-derivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |